Modelos de datos seleccionados

Debe iniciar sesión para seleccionar modelos de datos para descargar o realizar un análisis.

270 Resultados de la búsqueda.
Relevancia Evaluación Nuevo primero Antiguo primero

Eligibility Syncope NCT01965899

- 28/9/21 - 1 formulario, 2 itemgroups, 15 items, 1 idioma
Itemgroups: Inclusion Criteria, Exclusion Criteria
Usability Study to Assess the Reveal LINQ Insertable Cardiac Monitor System; ODM derived from: https://clinicaltrials.gov/show/NCT01965899

Eligibility Atrial Fibrillation NCT00580216

- 20/9/21 - 1 formulario, 1 itemgroup, 11 items, 1 idioma
Itemgroup: Inclusion Criteria
Evaluation of Weekly Subcutaneous Biotinylated Idraparinux Versus Oral Adjusted-dose Warfarin to Prevent Stroke and Systemic Thromboembolic Events in Patients With Atrial Fibrillation; ODM derived from: https://clinicaltrials.gov/show/NCT00580216

Eligibility Atrial Fibrillation NCT00829478

- 20/9/21 - 1 formulario, 2 itemgroups, 17 items, 1 idioma
Itemgroups: Inclusion Criteria, Exclusion Criteria
Improving the Quality of Care for Atrial Fibrillation by Promoting Patient-Centered Decision Making; ODM derived from: https://clinicaltrials.gov/show/NCT00829478

Eligibility NCT00293943 Atrial Fibrillation - Eligibility

- 17/9/21 - 1 formulario, 3 itemgroups, 56 items, 2 idiomas
Itemgroups: Inclusion Criteria, Exclusion Criteria, Medical Concepts
ODM derived from http://clinicaltrials.gov/show/NCT00293943

Eligibility Atrial Fibrillation NCT01747746

- 17/9/21 - 1 formulario, 2 itemgroups, 13 items, 1 idioma
Itemgroups: Inclusion Criteria, Exclusion Criteria
Anticoagulation With Rivaroxaban in Cardioversion -The ARC Study; ODM derived from: https://clinicaltrials.gov/show/NCT01747746

Eligibility Atrial Fibrillation With 2 or 3° AV or Bifascicular Bundle Branch (BBB) Block NCT01700244

- 17/9/21 - 1 formulario, 2 itemgroups, 20 items, 1 idioma
Itemgroups: Inclusion Criteria, Exclusion Criteria
Evaluation of a New Cardiac Pacemaker; ODM derived from: https://clinicaltrials.gov/show/NCT01700244

Eligibility Atrial Fibrillation NCT01805531

- 17/9/21 - 1 formulario, 2 itemgroups, 11 items, 1 idioma
Itemgroups: Inclusion Criteria, Exclusion Criteria
Satisfaction/Quality of Life With Rivaroxaban in SPAF (Stroke Prevention in Atrial Fibrillation) Indication; ODM derived from: https://clinicaltrials.gov/show/NCT01805531

Eligibility Atrial Fibrillation NCT01185587

- 17/9/21 - 1 formulario, 2 itemgroups, 18 items, 1 idioma
Itemgroups: Inclusion Criteria, Exclusion Criteria
Sodium Channel Splicing in Heart Failure Trial; ODM derived from: https://clinicaltrials.gov/show/NCT01185587

Stroke Secondary to Atrial Fibrillation, NCT01925755 - Eligibility Stroke Secondary to Atrial Fibrillation, NCT01925755

- 28/9/20 - 1 formulario, 2 itemgroups, 9 items, 1 idioma
Itemgroups: Inclusion Criteria, Exclusion Criteria
Non-interventional Local Study on Prescription Behavior of Anticoagulation Therapy in Secondary Stroke Prevention in Atrial Fibrillation Patients; ODM derived from: https://clinicaltrials.gov/show/NCT01925755

Eligibility Longstanding Persistent Atrial Fibrillation NCT01558635

- 5/7/20 - 1 formulario, 2 itemgroups, 16 items, 1 idioma
Itemgroups: Inclusion Criteria, Exclusion Criteria
Safety and Efficacy of Cryothermia to Treat Longstanding Persistent Atrial Fibrillation (AF); ODM derived from: https://clinicaltrials.gov/show/NCT01558635

Eligibility Fibrillation, Atrial NCT00911300

- 9/6/20 - 1 formulario, 2 itemgroups, 16 items, 1 idioma
Itemgroups: Inclusion Criteria, Exclusion Criteria
Evaluation of Fondaparinux in Patients With a Heart Rhythm Disturbance Who Undergo Restoration of Normal Heart Rhythm; ODM derived from: https://clinicaltrials.gov/show/NCT00911300

Eligibility Non-valvular Atrial Fibrillation NCT02422602

- 5/3/20 - 1 formulario, 2 itemgroups, 10 items, 1 idioma
Itemgroups: Inclusion Criteria, Exclusion Criteria
Better Adherence With New Oral Anticoagulant in Atrial Fibrillation : Effectiveness of a Personalized Education Program; ODM derived from: https://clinicaltrials.gov/show/NCT02422602

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial